Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)
A

Who Is a Candidate for Watch and Wait Therapy in MCL / What Are the Clinical and Biologic Features of Successfully Monitored MCL Patients?

By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Anita Kumar
By Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019) FEATURING Anita Kumar
15 views
October 18, 2019
0 Comments
Login to view comments. Click here to Login

Featured Video

13:04
Winship Cancer Institute - Emory University

Treatment-Related Quality of Life in MF

Feat. A. Hunter

Featured Video

15:14
Icahn School of Medicine at Mount Sinai

Safety Profile of Ruxolitinib in Patients With MF

Feat. D. Tremblay

Related Content

AUTOPLAY
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
10:27
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Rates of CRS and ICANS From CIBMTR Data o…

Feat. J. DiPersio
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
31:12
UChicago Medicine

Practice-Changing Abstracts in NHL and HL From ASH 2023

Feat. S. Smith
37:44
University of Colorado Division of Hematology

Summary and Practice Impacts of Recent Updates in B-Cell Lymphomas

Feat. M. Kamdar
04:34
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "Highlights and Key Takeaways in MCL"

Feat. P. Jain
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
26:58
Total Health

Update on Cellular Therapy in Lymphoma

Feat. B. Randolph
16:05
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: What Is High Risk MCL and How Should We Treat It

Feat. A. Kumar
06:43
Insights from 2023 ASH Annual Meeting

ASH 2023 Summary: "The Best of MCL - Highlights & Key Takea…

Feat. V. Yazbeck
07:22
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Hypertension in Pts With CLL and Other Heme…

Feat. A. Ferrajoli
05:24
Chan Cheah

Efficacy of Pirtobrutinib in Covalent BTKi Pre-Treated R/R MCL: Addi…

05:28
GRACE

3L Treatment for Mantle Cell Lymphoma

Feat. T. Phillips
12:54
The University of Alabama at Birmingham School of Medicine

Tips and Tricks in Treatment of MCL: Choice of Regimens and Dosing C…

Feat. M. Narkhede
44:19
University of Colorado Division of Hematology

Mantle Cell Lymphoma: Challenges & Prospects

Feat. J. Jasem
06:18
Insights from 2023 ASCO® Annual Meeting

ASCO® 2023 Insights: "Pirtobrutinib in cBTKi Pre-Treated MCL - …

Feat. N. Shah
04:13
GRACE

The TRIANGLE Study: Ibrutinib Maintenance for MCL

Feat. T. Phillips
07:47
PrecisCa

Treatment Approach for Older Patients With Mantle Cell Lymphoma: A D…

Feat. M. Kamdar
14:51
SOHO 2023 Eleventh Annual Meeting

SOHO 2023: Is Stem Cell Transplantation Still Necessary in Frontline…

Feat. T. Fenske
08:19
ASH 2022 Conference Coverage

ASH 2022 Results From the Phase 1/2 BRUIN Study: Safety & Tolera…

Feat. N. Shah